A carregar...
Clinical development of neridronate: potential for new applications
Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget’s disease of bone (PDB). A characteristic property of neridronate is that it can be administered both intravenously and intramuscularly, providing a useful system for administration i...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3622395/ https://ncbi.nlm.nih.gov/pubmed/23589692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S35788 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|